Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_assertion type Assertion NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_head.
- NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_assertion wasGeneratedBy ECO_0000203 NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_provenance.
- NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_assertion wasDerivedFrom lhgdn-20090331 NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_provenance.
- NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_assertion SIO_000772 17962208 NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_provenance.
- NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_assertion evidence source_evidence_literature NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_provenance.
- NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_assertion description "[NRG3 was expressed in 42% of breast cancers studied/was preferentially expressed in breast tumors co-expressing EGFR/HER4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113211.RAR-59Kj1OcVkSCZzlMZ_OZy3OakzK3oKFQvrOUW9Boxo130_provenance.